Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 55.3B | 55.9B | 53.4B | 53.4B |
Cost of revenue | 7.8B | 7.6B | 6.7B | 6.6B |
Gross profit | 47.4B | 48.3B | 46.6B | 46.7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 9.4B | 10.4B | 19.0B | 20.5B |
Other operating expenses | 8.0B | 7.9B | — | — |
Operating income | 15.6B | 9.9B | 14.8B | 13.6B |
Non operating interest income | ||||
Income | 199M | 198M | — | — |
Expense | 4.3B | 4.5B | — | — |
Other income expense | 346M | 76M | -2.0B | -2.5B |
Pretax income | 11.8B | 5.6B | 12.8B | 11.1B |
Tax provision | 2.7B | 1.3B | 3.1B | 2.5B |
Net income | 9.1B | 4.3B | 9.7B | 8.6B |
Basic EPS | 41.7 | — | 44.6 | 39.7 |
Diluted EPS | 41.7 | — | 44.6 | 39.7 |
Basic average shares | 216.1M | — | 216.4M | 216.4M |
Diluted average shares | 216.1M | — | 216.4M | 216.4M |
EBITDA | 29.8B | 29.5B | 28.7B | 27.4B |
Net income from continuing op. | 11.8B | 5.6B | 12.8B | 11.1B |
Minority interests | -39M | -94M | -50M | -35M |
Preferred stock dividends | — | — | — | — |